Answers are grounded in this paper and cite their sources.
Epidemiological review reveals widespread antiretroviral resistance in treated individuals, highlighting threats to long-term disease control.
Combinations of antiretroviral drugs have proven remarkably effective in controlling the progression of HIV disease and prolonging survival, but these benefits can be compromised by the development of drug resistance. About 50 percent of patients receiving antiretroviral therapy in the United States are estimated to harbor viruses that express resistance to at least one of the available antiretroviral drugs.
No takes yet. Share an insight, caveat, or question.
Clavel et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: